The UCLA Jonsson Comprehensive Cancer Center is one of 30 leading cancer centers in the United States participating in the National Comprehensive Cancer Network (NCCN). As a member of the NCCN, the Jonsson Cancer Center joins the experts from the NCCN to diagnose and treat patients with cancer, with a particular focus on uncommon, complex and aggressive forms of cancer.
As a top-tier academic cancer center are located in one of the nation's most-populous cities, the Jonsson Cancer Center and its researchers are involved in the creation of the NCCN Clinical Practice Guidelines—the recognized standard for clinical direction in cancer care, and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine.
In addition to joining the panels behind the NCCN Guidelines and their derivatives, experts from the UCLA Jonsson Comprehensive Cancer Center work with NCCN to provide continuing education; policy and advocacy outreach; best practices information; organization of clinical trials and research; global adaptations and translations; and up-to-date patient information. Visit NCCN.org to learn more about the various programs and their role in improving cancer care worldwide.
The UCLA Jonsson Comprehensive Cancer Center clinicians provide the highest quality of cancer care available through UCLA Health at hospitals and cancer care locations across Southern California.
With a membership of more than 500 physicians and scientists, the UCLA Jonsson Comprehensive Cancer Center provides the best in experimental and traditional cancer treatments
The UCLA Jonsson Comprehensive Cancer Center is a leader in community- and population-based cancer control research, and offers educational and community-building opportunities with community partners that focus on underserved low-income and minority communities
The UCLA Jonsson Comprehensive Cancer Center’s Office of Cancer Training and Education is committed to exceptional cancer research education, mentorship and training for the next generation of cancer researchers